Initiation:
Identify a high-eod overview of the requirements, documents, and process flow map involved in the TT from the European-based pharmaceutical manufacturer to the third country sites 20°. outside of Europe for release and sale in the EU only: °
Planning: Discuss the potential gaps and risks in great detail and propose solutions to address these issues 30%